Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > dang

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Jan 20, 2021 3:34pm

96 Views

Post# 32335978

RE:RE:RE:dang

Ironically couple a weeks ago we wanted THTX to stay over US $3 now we are struggling with Canadian $3!

palinc2000 wrote: Checking back on my order it was placed at 11.46 this morning and the ask was 2,83 by then but my bid was 2,82 I dont expect to get filled today and hopefully never

scarlet1967 wrote: Some 6000 shares moved the SP by over 3% not want be a downer by you might get that order filled, hopefully not...